PhRMA's SVP says newspaper overlooks benefit of DTC

PhRMA SVP Ken Johnson, responding to a Christian Science Monitor piece critical of drug DTC advertising, said the newspaper "unfortunately overlooks the educational benefits of direct-to-consumer advertising of prescription medicines."
You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical